---
title: "GlucoTrack names Erik Emerson CEO, Paul Goode CTO in Lōkahi deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292678856.md"
description: "GlucoTrack appointed Erik Emerson as CEO and Paul Goode as CTO following its business combination with Lōkahi Therapeutics. Goode retains his role as CEO of the CBGM subsidiary."
datetime: "2026-07-14T21:40:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292678856.md)
  - [en](https://longbridge.com/en/news/292678856.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292678856.md)
generator: "portal-rs"
---

# GlucoTrack names Erik Emerson CEO, Paul Goode CTO in Lōkahi deal

-   GlucoTrack named Erik Emerson chief executive officer following the completion of its business combination with Lōkahi Therapeutics. \* Paul Goode was appointed chief technical officer of the combined company, retaining responsibility as chief executive officer of the CBGM subsidiary. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607141740PRIMZONEFULLFEED9762297) on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)

## Related News & Research

- [GlucoTrack unit Lokahi Therapeutics expands ai2 Futures Lab collaboration with University of Georgia](https://longbridge.com/en/news/296614954.md)
- [GlucoTrack Shareholders Approve Key Governance and Capital Actions](https://longbridge.com/en/news/296385751.md)
- [Glucotrack regains Nasdaq stockholders’ equity compliance, secures continued listing](https://longbridge.com/en/news/296101788.md)
- [GlucoTrack holds annual shareholder meeting with 36.1% of shares represented](https://longbridge.com/en/news/296360186.md)
- [GlucoTrack to issue 2,505,513 unregistered shares to White Lion Capital under stock purchase agreement amendment](https://longbridge.com/en/news/295445026.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**